CASI Pharmaceuticals Inc (CASI) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)
Last casi pharmaceuticals, inc. - ordinary shares earnings: 11/12 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
casipharmaceuticals.com/investor-relations
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $4.56 million, and the earnings are expected to come in at -$0.62 per share. The full year 2024's revenue is expected to be $19.8 million and the earnings are expected to be -$2.56 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 6 Warning Signs with CASI. Revenue estimates for CASI Pharmaceuticals Inc ( NASDAQ:CASI ) have remained stable at $19.8 million for the full year 2024 and at $46 million for 2025 over the past 90 days. Earnings estimates for CASI Pharmaceuticals Inc ( NASDAQ:CASI ) have also remained stable at -$2.56 per share for the full year 2024 and at -$2.13 per share for 2025 over the past 90 days. In the previous quarter of June 30, 2024, CASI Pharmaceuticals Inc's ( NASDAQ:CASI ) actual revenue was $3.98 million, which missed analysts' revenue expectations of $4.431 million by -10.2%. CASI Pharmaceuticals Inc's ( NASDAQ:CASI ) actual earnings were -$0.52 per sha
Show less
Read more
Impact Snapshot
Event Time:
CASI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CASI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CASI alerts
High impacting CASI Pharmaceuticals, Inc. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CASI
News
- CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results [Yahoo! Finance]Yahoo! Finance
- CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial ResultsAccesswire
- CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune ThrombocytopeniaAccesswire
CASI
Earnings
- 8/16/24 - Beat
CASI
Sec Filings
- 12/26/24 - Form 6-K
- 12/23/24 - Form F-3/A
- 12/20/24 - Form F-3
- CASI's page on the SEC website